Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ecopetrol SA

8.78
-0.2000-2.23%
Post-market: 8.75-0.0300-0.34%19:50 EDT
Volume:2.68M
Turnover:23.60M
Market Cap:18.05B
PE:5.90
High:8.96
Open:8.90
Low:8.72
Close:8.98
52wk High:11.05
52wk Low:7.21
Shares:2.06B
Float Shares:233.42M
Volume Ratio:1.79
T/O Rate:1.15%
Dividend:0.99
Dividend Rate:11.29%
EPS(TTM):1.49
EPS(LYR):1.65
ROE:16.46%
ROA:6.90%
PB:0.95
PE(LYR):5.33

Loading ...

Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC)

GlobeNewswire
·
Aug 26

Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI® (lecanemab)

GlobeNewswire
·
Aug 25

Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity

GlobeNewswire
·
Aug 21

Press Release: Decisions of the Board of Directors of Ecopetrol S.A.

Dow Jones
·
Aug 20

Madrigal Receives European Commission Approval for Rezdiffra™ (resmetirom) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis

GlobeNewswire
·
Aug 20

European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors

GlobeNewswire
·
Aug 18

Ecopetrol Q2 Net Income, Sales Fall

MT Newswires Live
·
Aug 13

Earnings Flash (EC) Ecopetrol Posts Q2 Total Revenue 29.669T Colombian Pesos, vs. FactSet Est. of 30.014T Pesos

MT Newswires Live
·
Aug 13

Ecopetrol Q2 Sales $7.061B Miss $7.240B Estimate

Benzinga
·
Aug 13

Autolus Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates

GlobeNewswire
·
Aug 12

Ecopetrol SA expected to post earnings of 34 cents a share - Earnings Preview

Reuters
·
Aug 09

Royalty Pharma Reports Second Quarter 2025 Results

GlobeNewswire
·
Aug 06

Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates

GlobeNewswire
·
Aug 05

Krystal Biotech Announces Second Quarter 2025 Financial and Operating Results

GlobeNewswire
·
Aug 04

Regeneron Reports Second Quarter 2025 Financial and Operating Results

GlobeNewswire
·
Aug 01

argenx Reports Half Year 2025 Financial Results and Provides Second Quarter Business Update

GlobeNewswire
·
Jul 31

TG Therapeutics to Host Conference Call on Second Quarter 2025 Financial Results and Business Update

GlobeNewswire
·
Jul 30

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW251, a Novel Glypican 3-Targeted Topoisomerase 1 Inhibitor Antibody-Drug Conjugate

GlobeNewswire
·
Jul 28

Press Release: Ecopetrol Announces Changes in Senior Management

Dow Jones
·
Jul 26

ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression

GlobeNewswire
·
Jul 25